Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Does enhanced recovery improve the survival rates of patients 3 years after undergoing surgery to remove a tumor in the colon?

Viannay P, Hamy A, Jaouen R, Caroli-Bosc FX, Luel C, Vasseur S, Levaillant M, Hamel JF, Venara A.

Int J Colorectal Dis. 2019 Mar;34(3):441-449. doi: 10.1007/s00384-018-3205-5. Epub 2018 Dec 7.

PMID:
30536115
2.

[Prolapse and urinary incontinence in women : place of the general practitioner].

Pastijn A, Vasseur S, Deneft F, Caillet M, Janssens F, Rozenberg S.

Rev Med Brux. 2018;39(4):273-279. French.

PMID:
30320988
3.

Optimization of the diagnosis of inherited colorectal cancer using NGS and capture of exonic and intronic sequences of panel genes.

Baert-Desurmont S, Coutant S, Charbonnier F, Macquere P, Lecoquierre F, Schwartz M, Blanluet M, Vezain M, Lanos R, Quenez O, Bou J, Bouvignies E, Fourneaux S, Manase S, Vasseur S, Mauillon J, Gerard M, Marlin R, Bougeard G, Tinat J, Frebourg T, Tournier I.

Eur J Hum Genet. 2018 Nov;26(11):1597-1602. doi: 10.1038/s41431-018-0207-2. Epub 2018 Jul 2.

PMID:
29967336
4.

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming.

Gouirand V, Guillaumond F, Vasseur S.

Front Oncol. 2018 Apr 19;8:117. doi: 10.3389/fonc.2018.00117. eCollection 2018. Review.

5.

Fountain of youth of pancreatic cancer cells: the extracellular matrix.

Gouirand V, Vasseur S.

Cell Death Discov. 2018 Jan 10;4:1. doi: 10.1038/s41420-017-0004-7. eCollection 2018 Dec. No abstract available.

6.

LIF Drives Neural Remodeling in Pancreatic Cancer and Offers a New Candidate Biomarker.

Bressy C, Lac S, Nigri J, Leca J, Roques J, Lavaut MN, Secq V, Guillaumond F, Bui TT, Pietrasz D, Granjeaud S, Bachet JB, Ouaissi M, Iovanna J, Vasseur S, Tomasini R.

Cancer Res. 2018 Feb 15;78(4):909-921. doi: 10.1158/0008-5472.CAN-15-2790. Epub 2017 Dec 21.

7.

Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts.

Nicolle R, Blum Y, Marisa L, Loncle C, Gayet O, Moutardier V, Turrini O, Giovannini M, Bian B, Bigonnet M, Rubis M, Elarouci N, Armenoult L, Ayadi M, Duconseil P, Gasmi M, Ouaissi M, Maignan A, Lomberk G, Boher JM, Ewald J, Bories E, Garnier J, Goncalves A, Poizat F, Raoul JL, Secq V, Garcia S, Grandval P, Barraud-Blanc M, Norguet E, Gilabert M, Delpero JR, Roques J, Calvo E, Guillaumond F, Vasseur S, Urrutia R, de Reyniès A, Dusetti N, Iovanna J.

Cell Rep. 2017 Nov 28;21(9):2458-2470. doi: 10.1016/j.celrep.2017.11.003.

8.

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions.

Olivares O, Mayers JR, Gouirand V, Torrence ME, Gicquel T, Borge L, Lac S, Roques J, Lavaut MN, Berthezène P, Rubis M, Secq V, Garcia S, Moutardier V, Lombardo D, Iovanna JL, Tomasini R, Guillaumond F, Vander Heiden MG, Vasseur S.

Nat Commun. 2017 Jul 7;8:16031. doi: 10.1038/ncomms16031.

9.

Akt targeting as a strategy to boost chemotherapy efficacy in non-small cell lung cancer through metabolism suppression.

Le Grand M, Berges R, Pasquier E, Montero MP, Borge L, Carrier A, Vasseur S, Bourgarel V, Buric D, André N, Braguer D, Carré M.

Sci Rep. 2017 Mar 23;7:45136. doi: 10.1038/srep45136.

10.

Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness.

Leca J, Martinez S, Lac S, Nigri J, Secq V, Rubis M, Bressy C, Sergé A, Lavaut MN, Dusetti N, Loncle C, Roques J, Pietrasz D, Bousquet C, Garcia S, Granjeaud S, Ouaissi M, Bachet JB, Brun C, Iovanna JL, Zimmermann P, Vasseur S, Tomasini R.

J Clin Invest. 2016 Nov 1;126(11):4140-4156. doi: 10.1172/JCI87734. Epub 2016 Oct 4.

11.

A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT.

Barraud M, Garnier J, Loncle C, Gayet O, Lequeue C, Vasseur S, Bian B, Duconseil P, Gilabert M, Bigonnet M, Maignan A, Moutardier V, Garcia S, Turrini O, Delpero JR, Giovannini M, Grandval P, Gasmi M, Ouaissi M, Secq V, Poizat F, Guibert N, Iovanna J, Dusetti N.

Oncotarget. 2016 Aug 16;7(33):53783-53796. doi: 10.18632/oncotarget.10776.

12.

LDL Receptor: An open route to feed pancreatic tumor cells.

Vasseur S, Guillaumond F.

Mol Cell Oncol. 2015 May 7;3(1):e1033586. doi: 10.1080/23723556.2015.1033586. eCollection 2016 Jan.

13.

TAp73 loss favors Smad-independent TGF-β signaling that drives EMT in pancreatic ductal adenocarcinoma.

Thakur AK, Nigri J, Lac S, Leca J, Bressy C, Berthezene P, Bartholin L, Chan P, Calvo E, Iovanna JL, Vasseur S, Guillaumond F, Tomasini R.

Cell Death Differ. 2016 Aug;23(8):1358-70. doi: 10.1038/cdd.2016.18. Epub 2016 Mar 4.

14.

Lipid metabolic reprogramming in cancer cells.

Beloribi-Djefaflia S, Vasseur S, Guillaumond F.

Oncogenesis. 2016 Jan 25;5:e189. doi: 10.1038/oncsis.2015.49. Review.

15.

[Pancreatic adenocarcinoma: a tumor highly dependent on lipoproteins].

Vasseur S, Guillaumond F.

Med Sci (Paris). 2015 Aug-Sep;31(8-9):728-30. doi: 10.1051/medsci/20153108009. Epub 2015 Sep 4. French. No abstract available.

16.

ER stress and hexosamine pathway during tumourigenesis: A pas de deux?

Vasseur S, Manié SN.

Semin Cancer Biol. 2015 Aug;33:34-9. doi: 10.1016/j.semcancer.2015.04.001. Epub 2015 Apr 27. Review.

PMID:
25931390
17.

Metabolic rewiring of pancreatic ductal adenocarcinoma: New routes to follow within the maze.

Olivares O, Vasseur S.

Int J Cancer. 2016 Feb 15;138(4):787-96. doi: 10.1002/ijc.29501. Epub 2015 Mar 18. Review.

18.

Cholesterol uptake disruption, in association with chemotherapy, is a promising combined metabolic therapy for pancreatic adenocarcinoma.

Guillaumond F, Bidaut G, Ouaissi M, Servais S, Gouirand V, Olivares O, Lac S, Borge L, Roques J, Gayet O, Pinault M, Guimaraes C, Nigri J, Loncle C, Lavaut MN, Garcia S, Tailleux A, Staels B, Calvo E, Tomasini R, Iovanna JL, Vasseur S.

Proc Natl Acad Sci U S A. 2015 Feb 24;112(8):2473-8. doi: 10.1073/pnas.1421601112. Epub 2015 Feb 9.

19.

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling.

Secq V, Leca J, Bressy C, Guillaumond F, Skrobuk P, Nigri J, Lac S, Lavaut MN, Bui TT, Thakur AK, Callizot N, Steinschneider R, Berthezene P, Dusetti N, Ouaissi M, Moutardier V, Calvo E, Bousquet C, Garcia S, Bidaut G, Vasseur S, Iovanna JL, Tomasini R.

Cell Death Dis. 2015 Jan 15;6:e1592. doi: 10.1038/cddis.2014.557.

20.

Pancreatic tumor cell metabolism: focus on glycolysis and its connected metabolic pathways.

Guillaumond F, Iovanna JL, Vasseur S.

Arch Biochem Biophys. 2014 Mar 1;545:69-73. doi: 10.1016/j.abb.2013.12.019. Epub 2014 Jan 3. Review.

PMID:
24393743
21.

Diversity of the clinical presentation of the MMR gene biallelic mutations.

Bougeard G, Olivier-Faivre L, Baert-Desurmont S, Tinat J, Martin C, Bouvignies E, Vasseur S, Huet F, Couillault G, Vabres P, Le Pessot F, Chapusot C, Malka D, Bressac-de Paillerets B, Tosi M, Frebourg T.

Fam Cancer. 2014 Mar;13(1):131-5. doi: 10.1007/s10689-013-9676-1.

PMID:
24068316
22.

The MDM2 285G-309G haplotype is associated with an earlier age of tumour onset in patients with Li-Fraumeni syndrome.

Renaux-Petel M, Sesboüé R, Baert-Desurmont S, Vasseur S, Fourneaux S, Bessenay E, Frébourg T, Bougeard G.

Fam Cancer. 2014 Mar;13(1):127-30. doi: 10.1007/s10689-013-9667-2.

PMID:
23884452
23.

The metabolic facet of pancreatic cancer: how hypoxia shapes fatal cancer cells.

Guillaumond F, Vasseur S.

Cell Cycle. 2013 Apr 15;12(8):1155-6. doi: 10.4161/cc.24489. Epub 2013 Apr 2. No abstract available.

24.

Strengthened glycolysis under hypoxia supports tumor symbiosis and hexosamine biosynthesis in pancreatic adenocarcinoma.

Guillaumond F, Leca J, Olivares O, Lavaut MN, Vidal N, Berthezène P, Dusetti NJ, Loncle C, Calvo E, Turrini O, Iovanna JL, Tomasini R, Vasseur S.

Proc Natl Acad Sci U S A. 2013 Mar 5;110(10):3919-24. doi: 10.1073/pnas.1219555110. Epub 2013 Feb 13.

25.

Vemurafenib potently induces endoplasmic reticulum stress-mediated apoptosis in BRAFV600E melanoma cells.

Beck D, Niessner H, Smalley KS, Flaherty K, Paraiso KH, Busch C, Sinnberg T, Vasseur S, Iovanna JL, Drießen S, Stork B, Wesselborg S, Schaller M, Biedermann T, Bauer J, Lasithiotakis K, Weide B, Eberle J, Schittek B, Schadendorf D, Garbe C, Kulms D, Meier F.

Sci Signal. 2013 Jan 29;6(260):ra7. doi: 10.1126/scisignal.2003057.

26.

TAp73 is required for macrophage-mediated innate immunity and the resolution of inflammatory responses.

Tomasini R, Secq V, Pouyet L, Thakur AK, Wilhelm M, Nigri J, Vasseur S, Berthezene P, Calvo E, Melino G, Mak TW, Iovanna JL.

Cell Death Differ. 2013 Feb;20(2):293-301. doi: 10.1038/cdd.2012.123. Epub 2012 Sep 14.

27.

Consequences of DJ-1 upregulation following p53 loss and cell transformation.

Vasseur S, Afzal S, Tomasini R, Guillaumond F, Tardivel-Lacombe J, Mak TW, Iovanna JL.

Oncogene. 2012 Feb 2;31(5):664-70. doi: 10.1038/onc.2011.268. Epub 2011 Jul 4.

PMID:
21725356
28.

Hypoxia induced tumor metabolic switch contributes to pancreatic cancer aggressiveness.

Vasseur S, Tomasini R, Tournaire R, Iovanna JL.

Cancers (Basel). 2010 Dec 16;2(4):2138-52. doi: 10.3390/cancers2042138.

29.

2009 version of the Chompret criteria for Li Fraumeni syndrome.

Tinat J, Bougeard G, Baert-Desurmont S, Vasseur S, Martin C, Bouvignies E, Caron O, Bressac-de Paillerets B, Berthet P, Dugast C, Bonaïti-Pellié C, Stoppa-Lyonnet D, Frébourg T.

J Clin Oncol. 2009 Sep 10;27(26):e108-9; author reply e110. doi: 10.1200/JCO.2009.22.7967. Epub 2009 Aug 3. No abstract available.

PMID:
19652052
30.

Silica encapsulated manganese perovskite nanoparticles for magnetically induced hyperthermia without the risk of overheating.

Kaman O, Pollert E, Veverka P, Veverka M, Hadová E, Knízek K, Marysko M, Kaspar P, Klementová M, Grünwaldová V, Vasseur S, Epherre R, Mornet S, Goglio G, Duguet E.

Nanotechnology. 2009 Jul 8;20(27):275610. doi: 10.1088/0957-4484/20/27/275610. Epub 2009 Jun 17.

PMID:
19531865
31.

DJ-1/PARK7 is an important mediator of hypoxia-induced cellular responses.

Vasseur S, Afzal S, Tardivel-Lacombe J, Park DS, Iovanna JL, Mak TW.

Proc Natl Acad Sci U S A. 2009 Jan 27;106(4):1111-6. doi: 10.1073/pnas.0812745106. Epub 2009 Jan 14.

32.

Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function.

Cano CE, Gommeaux J, Pietri S, Culcasi M, Garcia S, Seux M, Barelier S, Vasseur S, Spoto RP, Pébusque MJ, Dusetti NJ, Iovanna JL, Carrier A.

Cancer Res. 2009 Jan 1;69(1):219-26. doi: 10.1158/0008-5472.CAN-08-2320.

33.

Molecular basis of the Li-Fraumeni syndrome: an update from the French LFS families.

Bougeard G, Sesboüé R, Baert-Desurmont S, Vasseur S, Martin C, Tinat J, Brugières L, Chompret A, de Paillerets BB, Stoppa-Lyonnet D, Bonaïti-Pellié C, Frébourg T; French LFS working group.

J Med Genet. 2008 Aug;45(8):535-8. doi: 10.1136/jmg.2008.057570. Epub 2008 May 29.

PMID:
18511570
34.

Sr-hexaferrite/maghemite composite nanoparticles-possible new mediators for magnetic hyperthermia.

Veverka P, Pollert E, Závěta K, Vasseur S, Duguet E.

Nanotechnology. 2008 May 28;19(21):215705. doi: 10.1088/0957-4484/19/21/215705. Epub 2008 Apr 23.

PMID:
21730584
35.

The three nucleotide deletion within the 3'untranslated region of MLH1 resulting in gene expression reduction is not a causal alteration in Lynch syndrome.

Tinat J, Baert-Desurmont S, Latouche JB, Vasseur S, Martin C, Bouvignies E, Frébourg T.

Fam Cancer. 2008;7(4):339-40. doi: 10.1007/s10689-008-9196-6. Epub 2008 May 22. No abstract available.

PMID:
18496770
36.

Magnetic nanoparticles and their applications in medicine.

Duguet E, Vasseur S, Mornet S, Devoisselle JM.

Nanomedicine (Lond). 2006 Aug;1(2):157-68. Review.

PMID:
17716105
37.

Regulation of apoptosis by the p8/prothymosin alpha complex.

Malicet C, Giroux V, Vasseur S, Dagorn JC, Neira JL, Iovanna JL.

Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2671-6. Epub 2006 Feb 14.

38.

p8 is a new target of gemcitabine in pancreatic cancer cells.

Giroux V, Malicet C, Barthet M, Gironella M, Archange C, Dagorn JC, Vasseur S, Iovanna JL.

Clin Cancer Res. 2006 Jan 1;12(1):235-41.

39.

Upregulation of the stress-associated gene p8 in mouse models of demyelination and in multiple sclerosis tissues.

Plant SR, Wang Y, Vasseur S, Thrash JC, McMahon EJ, Bergstralh DT, Arnett HA, Miller SD, Carson MJ, Iovanna JL, Ting JP.

Glia. 2006 Apr 1;53(5):529-37.

40.

Interaction of the stress protein p8 with Jab1 is required for Jab1-dependent p27 nuclear-to-cytoplasm translocation.

Malicet C, Hoffmeister A, Moreno S, Closa D, Dagorn JC, Vasseur S, Iovanna JL.

Biochem Biophys Res Commun. 2006 Jan 6;339(1):284-9. Epub 2005 Nov 15.

PMID:
16300740
41.

Impact of the MDM2 SNP309 and p53 Arg72Pro polymorphism on age of tumour onset in Li-Fraumeni syndrome.

Bougeard G, Baert-Desurmont S, Tournier I, Vasseur S, Martin C, Brugieres L, Chompret A, Bressac-de Paillerets B, Stoppa-Lyonnet D, Bonaiti-Pellie C, Frebourg T.

J Med Genet. 2006 Jun;43(6):531-3. Epub 2005 Oct 28.

42.

Folate-conjugated iron oxide nanoparticles for solid tumor targeting as potential specific magnetic hyperthermia mediators: synthesis, physicochemical characterization, and in vitro experiments.

Sonvico F, Mornet S, Vasseur S, Dubernet C, Jaillard D, Degrouard J, Hoebeke J, Duguet E, Colombo P, Couvreur P.

Bioconjug Chem. 2005 Sep-Oct;16(5):1181-8.

PMID:
16173796
43.

Eotaxin-3/CCL26 gene expression in intestinal epithelial cells is up-regulated by interleukin-4 and interleukin-13 via the signal transducer and activator of transcription 6.

Blanchard C, Durual S, Estienne M, Emami S, Vasseur S, Cuber JC.

Int J Biochem Cell Biol. 2005 Dec;37(12):2559-73. Epub 2005 Jul 21.

PMID:
16084752
44.

Biochemical changes in response to intensive resistance exercise training in the elderly.

Bautmans I, Njemini R, Vasseur S, Chabert H, Moens L, Demanet C, Mets T.

Gerontology. 2005 Jul-Aug;51(4):253-65.

PMID:
15980654
45.

Inactivation of stress protein p8 increases murine carbon tetrachloride hepatotoxicity via preserved CYP2E1 activity.

Taïeb D, Malicet C, Garcia S, Rocchi P, Arnaud C, Dagorn JC, Iovanna JL, Vasseur S.

Hepatology. 2005 Jul;42(1):176-82.

PMID:
15962327
46.
47.

Choosing where to deliver: decision criteria among women with low-risk pregnancies in France.

Combier E, Zeitlin J, de Courcel N, Vasseur S, Lalouf A, Amat-Roze JM, de Pouvourville G.

Soc Sci Med. 2004 Jun;58(11):2279-89.

PMID:
15047084
48.

[p8 gene is necessary for tumor establishment].

Vasseur S, Iovanna JL.

Med Sci (Paris). 2003 Dec;19(12):1259-64. Review. French.

49.

p8 improves pancreatic response to acute pancreatitis by enhancing the expression of the anti-inflammatory protein pancreatitis-associated protein I.

Vasseur S, Folch-Puy E, Hlouschek V, Garcia S, Fiedler F, Lerch MM, Dagorn JC, Closa D, Iovanna JL.

J Biol Chem. 2004 Feb 20;279(8):7199-207. Epub 2003 Dec 1.

Supplemental Content

Loading ...
Support Center